Yiping Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yiping Xu has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Zijian Wang
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
21 shared publicationsKaifeng Rao
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
12 shared publicationsMei Ma
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
10 shared publicationsRuili Xie
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, China
7 shared publications- Xiaozhong Gao
Beijing Key Laboratory for Source Control Technology of Water Pollution, Beijing Forestry University, Beijing 100083, China
6 shared publications - Rui Hou
Guangdong Provincial Key Laboratory of Water Quality Improvement and Ecological Restoration for Watersheds, School of Ecology, Environment and Resources, Guangdong University of Technology, Guangzhou 510006, China
4 shared publications
Latest Publications
- 7 October 2026
- Published by American Chemical Society (ACS) in ACS ES&T Toxicology
AMOI: A Conceptual Framework for Deep Integration of Omics, ML, and AOPs─A Critical Review with Illustrative Case Analysis
Although new approach methodologies (NAMs), such as omics technologies, machine learning (ML) and adverse outcome pathways (AOPs), have advanced chemical risk assessment individually, their simple serial integration─omics → ML → AOP─cannot fully exploit the predictive and mechanistic potential of these approaches. Based on a systematic review, we propose a paradigm shift toward deep integration, termed AOP-guided, ML-driven multiomics integration (AMOI), in which ML algorithms leverage dose–response and temporal information from multiomics data, as well as the causal AOP structure, to iteratively quantify, refine and update quantitative AOPs (qAOPs). Through an illustrative case study on AhR activation and aromatase inhibition, we demonstrate that omics-based benchmark doses (BMDomics) can anchor qAOPs and that ML facilitates cross-layer multiomics integration and key event relationship (KER) quantification. However, the case also highlights critical limitations, particularly the unreliability of complex ML models under small sample constraints. We therefore provide practical guidelines for selecting an ML strategy across sample size regimes and outline a roadmap for community-driven data infrastructure. This work provides a conceptual framework within NAMs, outlining a path from conceptual exploration toward regulatory-ready next-generation risk assessment (NGRA).
- 7 October 2026
- Published by American Chemical Society (ACS) in ACS ES&T Toxicology
AMOI: A Conceptual Framework for Deep Integration of Omics, ML, and AOPs─A Critical Review with Illustrative Case Analysis
Although new approach methodologies (NAMs), such as omics technologies, machine learning (ML) and adverse outcome pathways (AOPs), have advanced chemical risk assessment individually, their simple serial integration─omics → ML → AOP─cannot fully exploit the predictive and mechanistic potential of these approaches. Based on a systematic review, we propose a paradigm shift toward deep integration, termed AOP-guided, ML-driven multiomics integration (AMOI), in which ML algorithms leverage dose–response and temporal information from multiomics data, as well as the causal AOP structure, to iteratively quantify, refine and update quantitative AOPs (qAOPs). Through an illustrative case study on AhR activation and aromatase inhibition, we demonstrate that omics-based benchmark doses (BMDomics) can anchor qAOPs and that ML facilitates cross-layer multiomics integration and key event relationship (KER) quantification. However, the case also highlights critical limitations, particularly the unreliability of complex ML models under small sample constraints. We therefore provide practical guidelines for selecting an ML strategy across sample size regimes and outline a roadmap for community-driven data infrastructure. This work provides a conceptual framework within NAMs, outlining a path from conceptual exploration toward regulatory-ready next-generation risk assessment (NGRA).
- 27 October 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (44) , 28359-28374
Hepatic and Renal Toxicity of Gardenia Yellow: Repeated-Dose Assessment and Human Oral Equivalent Dose Prediction via IVIVE
Gardenia yellow, an edible pigment derived from Gardenia jasminoides, has wide food applications; however, its safety profile is insufficiently defined. In this study, we characterized the composition of gardenia yellow and simulated its gastrointestinal digestion, absorption, and metabolism using an in vitro gastrointestinal model. Its hepatotoxicity and nephrotoxicity were assessed using the HepaRG and RPTEC/TERT1 cell lines via cellular viability, oxidative stress, and mitochondrial dysfunction assays. Its lowest effective concentration (LEC), determined after 14 days of repeated exposure, was used to estimate its oral equivalent dose (OED) via the in vitro-to-in vivo extrapolation (IVIVE) method. Crocin, the primary bioactive component of gardenia yellow (44.96%), exhibited 4.68 ± 1.00% oral bioavailability and was biotransformed to crocetin (30.47 ± 1.95%) in the colon. Crocetin induced oxidative stress and mitochondrial dysfunction in hepatic and renal cells. The predicted oral equivalent dose for gardenia yellow (1.43 g/(kg·bw·day)) exceeded the typical Chinese dietary exposure, indicating a favorable safety margin.
- 27 October 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (44) , 28359-28374
Hepatic and Renal Toxicity of Gardenia Yellow: Repeated-Dose Assessment and Human Oral Equivalent Dose Prediction via IVIVE
Gardenia yellow, an edible pigment derived from Gardenia jasminoides, has wide food applications; however, its safety profile is insufficiently defined. In this study, we characterized the composition of gardenia yellow and simulated its gastrointestinal digestion, absorption, and metabolism using an in vitro gastrointestinal model. Its hepatotoxicity and nephrotoxicity were assessed using the HepaRG and RPTEC/TERT1 cell lines via cellular viability, oxidative stress, and mitochondrial dysfunction assays. Its lowest effective concentration (LEC), determined after 14 days of repeated exposure, was used to estimate its oral equivalent dose (OED) via the in vitro-to-in vivo extrapolation (IVIVE) method. Crocin, the primary bioactive component of gardenia yellow (44.96%), exhibited 4.68 ± 1.00% oral bioavailability and was biotransformed to crocetin (30.47 ± 1.95%) in the colon. Crocetin induced oxidative stress and mitochondrial dysfunction in hepatic and renal cells. The predicted oral equivalent dose for gardenia yellow (1.43 g/(kg·bw·day)) exceeded the typical Chinese dietary exposure, indicating a favorable safety margin.
- 9 August 2025
- Published by Elsevier in Water Research
- Vol. 287 (Pt A) , 124381
Decoding dynamic water concentration fluctuations in passive sampling: Triphasic modeling-experiment-field validation with PRC-based stratification
- 9 August 2025
- Published by Elsevier in Water Research
- Vol. 287 (Pt A) , 124381
Decoding dynamic water concentration fluctuations in passive sampling: Triphasic modeling-experiment-field validation with PRC-based stratification
- 9 January 2025
- Published by Elsevier in Environmental Pollution
- Vol. 367, 125666
Systematic evaluation of sampling rate influences and variability in POCIS using meta-analysis and quantitative structure property relationship (QSPR)
- 9 January 2025
- Published by Elsevier in Environmental Pollution
- Vol. 367, 125666
Systematic evaluation of sampling rate influences and variability in POCIS using meta-analysis and quantitative structure property relationship (QSPR)
- 14 February 2024
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 58 (8) , 3677-3689
Fish Physiologically Based Toxicokinetic Modeling Approach for In Vitro–In Vivo and Cross-Species Extrapolation of Endocrine-Disrupting Chemicals in Risk Assessment
High-throughput in vitro assays combined with in vitro-in vivo extrapolation (IVIVE) leverage in vitro responses to predict the corresponding in vivo exposures and thresholds of concern. The integrated approach is also expected to offer the potential for efficient tools to provide estimates of chemical toxicity to various wildlife species instead of animal testing. However, developing fish physiologically based toxicokinetic (PBTK) models for IVIVE in ecological applications is challenging, especially for plausible estimation of an internal effective dose, such as fish equivalent concentration (FEC). Here, a fish PBTK model linked with the IVIVE approach was established, with parameter optimization of chemical unbound fraction, pH-dependent ionization and hepatic clearance, and integration of temperature effect and growth dilution. The fish PBTK-IVIVE approach provides not only a more precise estimation of tissue-specific concentrations but also a reasonable approximation of FEC targeting the estrogenic potency of endocrine-disrupting chemicals. Both predictions were compared with in vivo data and were accurate for most indissociable/dissociable chemicals. Furthermore, the model can help determine cross-species variability and sensitivity among the five fish species. Using the available IVIVE-derived FEC with target pathways is helpful to develop predicted no-effect concentration for chemicals with similar mode of action and support screening-level ecological risk assessment.
- 14 February 2024
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 58 (8) , 3677-3689
Fish Physiologically Based Toxicokinetic Modeling Approach for In Vitro–In Vivo and Cross-Species Extrapolation of Endocrine-Disrupting Chemicals in Risk Assessment
High-throughput in vitro assays combined with in vitro-in vivo extrapolation (IVIVE) leverage in vitro responses to predict the corresponding in vivo exposures and thresholds of concern. The integrated approach is also expected to offer the potential for efficient tools to provide estimates of chemical toxicity to various wildlife species instead of animal testing. However, developing fish physiologically based toxicokinetic (PBTK) models for IVIVE in ecological applications is challenging, especially for plausible estimation of an internal effective dose, such as fish equivalent concentration (FEC). Here, a fish PBTK model linked with the IVIVE approach was established, with parameter optimization of chemical unbound fraction, pH-dependent ionization and hepatic clearance, and integration of temperature effect and growth dilution. The fish PBTK-IVIVE approach provides not only a more precise estimation of tissue-specific concentrations but also a reasonable approximation of FEC targeting the estrogenic potency of endocrine-disrupting chemicals. Both predictions were compared with in vivo data and were accurate for most indissociable/dissociable chemicals. Furthermore, the model can help determine cross-species variability and sensitivity among the five fish species. Using the available IVIVE-derived FEC with target pathways is helpful to develop predicted no-effect concentration for chemicals with similar mode of action and support screening-level ecological risk assessment.
- 21 June 2022
- Published by Elsevier in Science of The Total Environment
- Vol. 842, 156816
An integrated screening strategy for novel AhR agonist candidate identification and toxicity confirmation in sediments
- 21 June 2022
- Published by Elsevier in Science of The Total Environment
- Vol. 842, 156816
An integrated screening strategy for novel AhR agonist candidate identification and toxicity confirmation in sediments